Merck's ($MRK) Gardasil, the human papillomavirus vaccine to prevent cervical cancer, garnered high safety marks in the second large-scale study of side effects in the past year.
Atreca, a San Carlos, CA-based biopharmaceutical company, captured a $6 million investment from the Bill & Melinda Gates Foundation to accelerate the discovery and development of novel vaccines and therapeutics for human infectious diseases.
Scientists from the U.K.'s Cardiff University are leading a NATO project to develop an anthrax vaccine.
Researchers at Emory University landed a $6 million grant from the Bill & Melinda Gates Foundation to help develop an effective vaccine for HIV/AIDS.
After launching its Japanese encephalitis vaccine in India, Austrian biotech group Intercell aims to win approval for other Asian countries.
With about 26,000 new cases of pertussis recorded so far this year, 2012 has marked the largest outbreak of the disease in the past 50 years, and scientists say more research is needed to find a better vaccine.
Lackluster results from a recent clinical trial has cast doubts on Sanofi's dengue fever vaccine, not to mention the Big Pharma's future sales expectations.
In a post-9/11 world, fears over pandemics and bioterrorism have renewed drug and vaccine development in the public sector, as national governments funnel research toward combating infectious diseases, like anthrax.
In Oklahoma, one of the states hit worst by the West Nile virus this year, researchers at the University of Oklahoma Health Sciences Center are working on a vaccine, and the findings have been promising so far.
On the Tanzanian island of Zanzibar, some individuals may not even need a vaccine to protect them against cholera. Research shows herd immunity has helped guard against the disease in sub-Saharan Africa.